Crohn's disease
A chronic inflammatory bowel disease affecting any part of the GI tract.
Crohn's disease (CD) is a chronic inflammatory bowel condition that can involve any part of the digestive tract, from the mouth to the anus. It is characterized by recurring periods of active symptoms, known as flare-ups, alternating with periods of remission. Common gastrointestinal symptoms include abdominal pain, diarrhea, fever, a sensation of abdominal fullness, and unintended weight loss. The disease can also cause complications beyond the gut, such as anemia, various skin rashes (which may stem from infections or conditions like pyoderma gangrenosum and erythema nodosum), arthritis, eye inflammation, and persistent fatigue. Chronic inflammation may lead to bowel obstruction, and individuals with Crohn's disease face a significantly elevated risk of developing colorectal and small bowel cancers.
The precise cause remains unknown, but the condition is thought to arise from a combination of environmental, immune, and microbial factors in people with a genetic predisposition. It involves a chronic inflammatory response where the immune system attacks the gastrointestinal tract, likely targeting microbial antigens. Despite being immune-related, it is not considered an autoimmune disease, as the immune system does not appear to target the body's own tissues. The underlying immune dysfunction may actually involve a form of immunodeficiency. Genetics account for roughly half the risk, with over seventy implicated genes. Tobacco smokers are about three times more likely to develop the disease than non-smokers, and onset is often triggered following an episode of gastroenteritis.
There is no known cure. Treatment focuses on managing symptoms, maintaining remission, and preventing relapse. For newly diagnosed patients, a short course of corticosteroids may be used for rapid symptom improvement, often alongside medications like methotrexate or a thiopurine to prevent recurrence. Smoking cessation is strongly advised. Annually, one in five patients requires hospitalization, and half will need surgery within a decade. Surgery is reserved for complications such as abscesses, certain obstructions, and cancers. Colonoscopy screening for bowel cancer is recommended every one to three years, beginning eight years after diagnosis.
Quick Facts
- Field
- Gastroenterology
- Symptoms
- Abdominal pain
- diarrhea (may be bloody)
- fever
- weight loss
- fatigue
- mouth sores
- reduced appetite
- Complications
- Anemia (iron deficiency)
- skin rashes
- arthritis
- bowel cancer
- Onset
- 20–29 years
- Duration
- Long term
- Causes
- Uncertain
- Diagnosis
- Biopsy, medical imaging
- Medication
- Corticosteroids
- biological therapy
- immunosuppressants such as azathioprine
- methotrexate
Facts from the source article.
Lore & Background
The disease was named after gastroenterologist Burrill Bernard Crohn, who in 1932, together with Leon Ginzburg and Gordon D. Oppenheimer at Mount Sinai Hospital in New York, described a series of people with inflammation of the terminal ileum of the small intestine, the area most commonly affected by the illness. The decision to name the disease after Crohn remains controversial as the disease had previously been described more than once. While Crohn, in his memoir, describes his original investigation of the disease, Ginzburg provided strong evidence of how he and Oppenheimer were the first to study the disease.
Reader's Guide
There is no known cure for Crohn's disease. Treatment options are intended to help with symptoms, maintain remission, and prevent relapse. In those newly diagnosed, a corticosteroid may be used for a brief period of time to improve symptoms rapidly, alongside another medication such as either methotrexate or a thiopurine to prevent recurrence. Cessation of smoking is recommended for people with Crohn's disease. One in five people with the disease is admitted to the hospital each year, and half of those with the disease will require surgery at some time during the next ten years. Surgery is kept to a minimum whenever possible, but it is sometimes essential for treating abscesses, certain bowel obstructions, and cancers. Checking for bowel cancer via colonoscopy is recommended every 1–3 years, starting eight years after the disease has begun.
Origins & Naming
The disease bears the name of gastroenterologist Burrill Bernard Crohn, but the story behind that naming is far from straightforward. In 1932, Crohn, alongside colleagues Leon Ginzburg and Gordon D. Oppenheimer at Mount Sinai Hospital in New York, published a description of patients showing inflammation in the terminal ileum, the segment of small intestine most frequently struck by the condition. Yet the disease had been documented before their work, and the decision to attach Crohn's name to it has remained a point of contention. In his own memoir, Crohn recounts his initial investigation, but Ginzburg later presented compelling evidence that he and Oppenheimer had been studying the condition first. The naming controversy thus sits alongside the medical history itself, a reminder that even the labels we use to define a condition carry their own disputes and politics.
The Body's Betrayal: Symptoms & Manifestations
Crohn's disease can strike virtually any segment of the gastrointestinal tract, and its symptoms reflect that wide reach. Abdominal pain, often localized to the lower right, frequently appears first, accompanied by diarrhea that may range from watery and high-volume in ileitis to smaller in quantity but more frequent in colitis. In severe cases, a person may experience more than twenty bowel movements a day and be roused from sleep to go. Beyond the gut, the disease can trigger anemia, joint inflammation, eye inflammation, fatigue, and distinctive skin conditions such as pyoderma gangrenosum or erythema nodosum. Perianal complications including fissures, fistulae, and abscesses are also prominent. Upper gastrointestinal involvement, once thought rare, is now recognized in roughly thirteen to sixteen percent of cases, presenting with difficulty swallowing, painful swallowing, and vomiting. Even the mouth may be affected by recurrent canker sores, though it remains unclear whether these are truly disease-related or simply common in the general population.
Roots & Risk: What Drives the Disease
No single cause explains Crohn's disease. Current understanding points to a convergence of genetic susceptibility, environmental exposures, immune dysregulation, and bacterial factors. Roughly half of a person's overall risk is tied to genetics, with more than seventy genes implicated. The immune system appears to mount a chronic inflammatory defense against the gut, possibly targeting microbial antigens, yet the condition does not behave like a classic autoimmune disorder in which the body attacks itself. Smoking stands out as a major modifiable risk: tobacco users face roughly three times the likelihood of developing the disease compared to non-smokers. A prior episode of gastroenteritis can serve as a trigger. Geographically, Crohn's disease has historically been more prevalent in Europe and North America, at about 3.2 per 1,000 people, than in Asia and Africa, though rates in the developing world have been climbing since the 1970s. Onset typically falls in adolescence and young adulthood, though it can emerge at any age, and males and females are affected in roughly equal numbers.
Living With It: Treatment & Prognosis
There is no known cure for Crohn's disease, and management centers on easing symptoms, sustaining remission, and preventing relapse. For newly diagnosed patients, a short course of corticosteroids may be prescribed to bring rapid relief, paired with a maintenance medication such as methotrexate or a thiopurine to guard against recurrence. Smoking cessation is strongly urged, given its role in worsening the condition. The disease carries significant long-term burdens: one in five patients is hospitalized each year, and half will need surgery within a decade. Surgeons aim to remove as little tissue as possible, yet intervention becomes essential for abscesses, certain obstructions, and cancers. The risk of colorectal and small bowel cancer is markedly elevated, prompting colonoscopic surveillance every one to three years beginning eight years after diagnosis. In 2015, inflammatory bowel disease as a whole accounted for 47,400 deaths worldwide, and those living with Crohn's face a slightly reduced life expectancy.
More in Common Diseases & Disorders
Spotted an error? Know more?
Reader corrections go straight into our review queue. Suggest an edit · How this site is sourced